FDA Approved Terzepatide for Weight Loss: All You Need to Know
2023-11-10 05:36:12 Dubai, United Arab Emirates (CNN) – The US Food and Drug Administration approved the use of the type 2 diabetes drug terzepatide in chronic weight management on Wednesday, making formal off-label use of an already widely prescribed drug for weight loss. The drug, called “Mounjaro” for diabetes, will take on the name “Zepbound” … Read more